_256_384.jpg)
Drug Approval | April 27, 2026
Cipla wins USFDA nod for first generic of Ventolin HFA strengthening respiratory push
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
The summit brought together over 150 doctors, researchers, and practitioners worldwide
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
Subscribe To Our Newsletter & Stay Updated
